Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001104659-24-081925
Filing Date
2024-07-23
Accepted
2024-07-23 16:43:58
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-1/A tm2415597-4_s1a.htm S-1/A 5378861
2 EXHIBIT 5.1 tm2415597d5_ex5-1.htm EX-5.1 23641
3 EXHIBIT 23.1 tm2415597d5_ex23-1.htm EX-23.1 2521
4 EXHIBIT 23.2 tm2415597d5_ex23-2.htm EX-23.2 2158
5 EX-FILING FEES tm2415597d5_ex-filingfees.htm EX-FILING FEES 93404
6 GRAPHIC lg_aeonbiopharma-4c.jpg GRAPHIC 14374
7 GRAPHIC tm2415597d5_ex5-1img001.jpg GRAPHIC 4295
8 GRAPHIC tm2415597d5_ex5-1img002.jpg GRAPHIC 2179
  Complete submission text file 0001104659-24-081925.txt   5530914
Mailing Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614
Business Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614 (949) 354-6499
AEON Biopharma, Inc. (Filer) CIK: 0001837607 (see all company filings)

EIN.: 853940478 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-274094 | Film No.: 241135184
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)